The disquietude of clozapine continuation during the COVID-19 pandemic.

dc.contributor.authorShoib, S.
dc.contributor.authorBharati-Sinha, V.
dc.contributor.authorJaved, S.
dc.contributor.authorGürcan, A.
dc.contributor.authorGürcan, G.
dc.contributor.authorDas, S.
dc.contributor.authorChandradasa, M.
dc.contributor.authorSaeed, F.
dc.date.accessioned2022-02-25T02:49:07Z
dc.date.available2022-02-25T02:49:07Z
dc.date.issued2022
dc.descriptionIndexed in MEDLINE.en_US
dc.description.abstractNo abstract availableen_US
dc.identifier.citationHealth Science Reports.2022;5(2):e506.en_US
dc.identifier.issn2398-8835
dc.identifier.urihttp://repository.kln.ac.lk/handle/123456789/24484
dc.language.isoenen_US
dc.publisherJohn Wiley and Sonsen_US
dc.subjectCOVID-19en_US
dc.titleThe disquietude of clozapine continuation during the COVID-19 pandemic.en_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Health Science Reports - 2022 - Shoib - The disquietude of clozapine continuation during the COVID‐19 pandemic.pdf
Size:
476.61 KB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
52 B
Format:
Item-specific license agreed upon to submission
Description: